Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
Richardson PG, Schjesvold F, Weisel K, Moreau P, Anderson LD Jr, White D, Rodriguez-Otero P, Sonneveld P, Engelhardt M, Jenner M, Corso A, Dürig J, Pavic M, Salomo M, Beksac M, Oriol A, Lindsay J, Liberati AM, Galli M, Robak P, Larocca A, Yagci M, Vural F, Kanate AS, Jiang R, Grote L, Peluso T, Dimopoulos M..
.
Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.
Ringshausen FC, Ewen R, Multmeier J, Monga B, Obradovic M, van der Laan R, Diel R.. Zhang L, et al.J Dermatol. 2021 Sep 6. doi: 10.1111/1346-8138.16126. Online ahead of print.J Dermatol. 2021.PMID: 34487567.Free PMC article.
.
Item in Clipboard
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3.
Cai B, Zhao J, Zhang Y, Liu Y, Ma C, Yi F, Zheng Y, Zhang L, Chen T, Liu H, Liu B, Gao C.. Review.
.
NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING.
Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, Mattson MP, Croteau DL, Bohr VA.